Neurowave Medical Technologies is interested in establishing licensing relationships with pharmaceutical or medical device companies with a sales presence in relevant market segments and geographies both in US and key International markets. Current market segments include:

• Chemotherapy Induced Nausea & Vomiting (CINV)
• Pregnancy Induced Nausea & Vomiting (PINV)
• Post-Operative Nausea & Vomiting (PONV)
• Motion Sickness Induced Nausea & Vomiting (MSNV)

Licensing opportunities exist in the United States and selected countries internationally.

For more information on partnership and licensing opportunities, please contact our Business Development group at info@neurowavemedical.com.